ISMPP Highlights
GPP4 – The Latest Update as Interest Grows
Excitement is building as the fourth iteration of the Good Publication Practice (also known as GPP4) guidance nears completion. At the 2022 European Meeting of ISMPP in late January, Dan Bridges (CEO, Nucleus Global) of the GPP4 Steering Committee presented information on the team’s progress. Watch the video to view this GPP4 update…
Building an ISMPP Educational Plan to Move Us All Forward
ISMPP consistently provides foundational educational resources for medical publication and communication professionals worldwide. To ensure alignment with the future educational needs of our members and to inform development of a longer-term, dynamic educational plan, the ISMPP Education Task Force launched a needs assessment survey in Q1 2021…
ISMPP-Sponsored Study on PLS Now Published in CMRO Presents Expert Perspectives
A new paper from the ISMPP PLS Perspectives Working Group has been published in Current Medical Research & Opinion. The paper presents findings from an ISMPP-sponsored, evidence-based study reporting on expert stakeholder perspectives to inform best practices for plain language summaries (PLS)…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
A Snapshot into Medical Affairs
What does a Medical Affairs team look like at a pharmaceutical/biotechnology company? Is it like a bag of M&M’S® with similar functions, or is it unique from company to company, like a fingerprint? We conducted a survey of ISMPP members in March 2021, that provides insights into what comprises Medical Affairs at pharmaceutical/biotechnology companies…
A Company’s Approach to Developing Publication Plain Language Summaries
Scientific publications tend to be written with a specialized audience in mind… Plain language summaries (PLS) of publications represent a way to communicate research more broadly using everyday language. Pfizer recognized this, and in early 2020 implemented a company-wide process for developing PLS…
Pressure in a Pandemic: Lessons for Communicating Scientific Research
Since the global pandemic started, there has been immense pressure to address the threat imposed by COVID-19. Researchers have risen to the challenge and, by working collaboratively, developed effective vaccines and identified some treatment options over an impressively short timescale…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
POLL RESULTS: Preprint Review Results in Added Author?
An external author posts the first draft of a preclinical manuscript on his/her department preprint server to invite review and comments from colleagues who performed some of the work yet did not meet all ICMJE criteria for full authorship. This author is now petitioning the author group to add one more colleague who provided insightful comments to the author byline…
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals